Trending Market News

Some Chinese rare earth suppliers are refusing to ship materials to the U.S. despite having export licenses, citing fears of repercussions from Beijing amid ongoing geopolitical tensions. The issue has become a priority for U.S. officials ahead of President Xi Jinping's planned September 24 visit to Washington. Prices for critical rare earths used in defense, semiconductors, and aerospace remain near record highs with tight supply.

• Chinese suppliers began halting shipments in early August after China sanctioned the Responsible Business Alliance, with companies fearing punishment for complying with Western due diligence frameworks
• Yttrium exports to the U.S. are only about half of 2024 levels, with some U.S. companies waiting over six months for mineral licenses despite China shipping larger volumes to other countries
• Japan faces even stricter restrictions, with China exporting zero terbium (down from 20 tons last year), 65% less gallium, and 98% less yttrium between January and August

Citigroup expects regulatory approval for its wholly-owned China brokerage unit as soon as September 2026, potentially coinciding with President Xi Jinping's planned visit to Washington. The bank plans to double headcount to approximately 100 staff by year-end to compete with Goldman Sachs, JPMorgan, and Morgan Stanley in China's securities market. The expansion targets underwriting and trading services for A-shares, leveraging Citi's existing corporate banking client base.

• Citi applied for the mainland Chinese brokerage license in late 2021 and has been hiring in preparation, aiming to reach around 100 staff by end of 2026 through internal transfers and external hires
• Wall Street rivals' China securities units saw significant 2025 profit growth: Goldman Sachs nearly tripled to 1.46 billion yuan ($217 million), JPMorgan quadrupled to 984 million yuan, and Morgan Stanley increased sevenfold to 138 million yuan
• The new unit will focus on A-share underwriting and trading, targeting sectors including technology, healthcare, consumer, financial institutions, AI and chip companies, complementing Citi's existing offshore China investment banking team

Oil prices are heading for their largest weekly gain since mid-July, with Brent up 7.1% and WTI up 9.8%, driven by escalating U.S.-Iran tensions that threaten Middle East supply. Recent U.S. attacks killed dozens including Iranian civilians, marking the fiercest clashes since July in a conflict now in its seventh month. Israel has threatened to target Iran's energy infrastructure while Iran has expanded its list of vessels subject to detention in the Strait of Hormuz.

• Brent crude reached $95.67 per barrel and WTI hit $91.56, with weekly gains of 7.1% and 9.8% respectively, the steepest since the week ended July 20
• Israeli Defense Minister warned Israel would 'cripple' Iran's military and civilian infrastructure including energy facilities, while the U.S. refuses talks unless Iran stops attacking commercial shipping in Hormuz
• Iraq increased oil exports to 2.34 million barrels per day in August from 1.35 million bpd in July, benefiting from Iranian approvals for Iraqi tankers to transit the Strait of Hormuz

Samsara, a San Francisco-based fleet management and IoT platform provider, reported fiscal Q2 earnings that exceeded expectations with profits rising 66% to 20 cents per share versus the 16 cents estimate. The company also beat revenue estimates and issued Q3 revenue guidance of $515 million, above the $510 million consensus. Samsara stock jumped over 12% in after-hours trading following the announcement.

• Annual recurring revenue (ARR) from subscriptions increased 30% to $2.125 billion, surpassing estimates of $2.096 billion
• Q3 revenue guidance of $515 million at midpoint exceeded analyst consensus of $510 million
• Stock had advanced 8% year-to-date in 2026 prior to the earnings report and holds an IBD Composite Rating of 68 out of 99

The U.S. FDA approved Ionis Pharmaceuticals' zilganersen (Zanvastro) for treating Alexander disease, marking the first approved therapy for this rare genetic brain disorder. The treatment is available for both adults and pediatric patients suffering from the condition, which affects fewer than 1,000 people in the U.S.

• Alexander disease is a neurological disorder caused by gene mutations that affects the brain's white matter, causing seizures and delayed physical and intellectual development
• In clinical trials, patients receiving a 50 mg dose showed statistically significant improvement in gait speed on a 10-meter walk test at 61 weeks
• This approval represents the first-ever treatment option for Alexander disease, addressing a significant unmet medical need for this rare condition

Lululemon Athletica lowered its annual revenue and profit forecasts for the second time, signaling mounting challenges for incoming CEO Heidi O'Neill. The athletic apparel company now expects fiscal 2026 revenue to decline 5% to 7%, a significant downgrade from its previous forecast of flat to down 1%, as it faces softening demand and increased competition from newer brands.

• Fiscal 2026 revenue now projected to decline 5% to 7%, versus prior guidance of flat to down 1%
• The downgrade comes as incoming CEO Heidi O'Neill prepares to take over amid challenging market conditions
• Company faces headwinds from softening consumer demand and intensifying competition from emerging athletic apparel brands

Zscaler's stock soared after beating fiscal fourth-quarter estimates with revenue of $898 million (25% year-over-year growth) and issuing upbeat guidance that exceeded Wall Street expectations. The cybersecurity company is benefiting from urgent demand for cyber tools amid rising AI-related security risks and is gaining momentum with its new agentic security tool.

• Annual recurring revenue rose 25% to $3.77 billion, beating the $3.75 billion estimate, with AI security bookings totaling $100 million and growing 50% sequentially quarter-over-quarter
• Full-year guidance projects revenue between $3.91 billion and $3.94 billion (vs. $3.90 billion estimate) and adjusted EPS of $4.86-$4.90 (vs. $4.60 estimate)
• CEO Jay Chaudhry said the company's agentic security tool, launched earlier this year, represents a 'fantastic opportunity' expected to accelerate rapidly into 2028 and 2029 as AI agent adoption increases

BASF, the German chemical company, filed a patent infringement lawsuit against Apple on September 3rd in U.S. District Court in Midland, Texas. The suit alleges that Apple violated BASF's patented face authentication technology across dozens of iPhone and iPad models.

• The lawsuit targets Apple's use of face authentication technology in multiple iPhone and iPad product lines
• BASF chose to file the case in the U.S. District Court in Midland, Texas, a common venue for patent litigation
• The German chemical giant is asserting its intellectual property rights against one of the world's largest technology companies

Volkswagen announced a target operating margin of 9% by 2030, more than doubling from 3.8% in the first half of 2026. The target is part of a sweeping turnaround plan approved by the company's supervisory board on Thursday. The transformation plan could involve cutting approximately 50,000 jobs, including management positions, to improve competitiveness.

• Operating margin target of 9% by 2030 represents a significant increase from the 3.8% achieved in the first six months of 2026
• The supervisory board unanimously approved a comprehensive transformation plan that may include workforce reductions of around 50,000 positions
• Job cuts would span across various levels including management roles as part of broader competitiveness improvements

Options trading volume surged in retail-favorite stocks including Robinhood, Tesla, Palantir, and SpaceX as traders placed heavily bullish bets despite September's historically weak performance. Call options outpaced puts by at least 2-to-1 across these names, with traders taking advantage of declining implied volatility as the VIX traded below 15. Robinhood saw the most bullish activity, jumping 15.95% and turning positive for the year.

• Robinhood experienced triple average daily volume with calls trading more than twice as heavily as puts, driven by Bitcoin's surge and its prediction markets business gaining traction
• Tesla and SpaceX both saw traders buying twice as many calls as puts ahead of Tesla's Cybercab event in Austin, with SpaceX reclaiming the $150 level for the first time since early July
• Implied volatility dropped sharply, with SpaceX's 30-day implied volatility in just the 4th percentile and about half its historical average since its June 12 IPO

Volkswagen announced plans to explore new SUV and pickup truck offerings for North America as part of a region-specific strategy amid trade tensions and shifting consumer demand. The German automaker is undergoing a global overhaul to streamline its lineup and better compete with Chinese rivals, while also expanding hybrid offerings in response to strong U.S. market demand.

• VW will explore opportunities in the body-on-frame B-segment, including robust SUVs and pickup trucks, though specific size details were not disclosed
• The company plans to expand hybrid offerings for U.S. customers as hybrid sales have surged while electric vehicle demand has weakened
• Marco Schubert, with over 25 years at VW, will lead North American strategy as part of recent executive changes announced this week

British fintech Revolut has received conditional approval from the U.S. Office of the Comptroller of the Currency for a national bank charter, advancing its goal to launch a full U.S. bank by 2027. The company still needs approval from the FDIC and Federal Reserve to proceed with banking operations.

• Revolut will inject approximately $95 million in capital into the new bank, which will be based in Stamford, Connecticut
• The bank will offer checking accounts, installment loans, credit cards, foreign exchange services, and plans to launch a stablecoin
• Revolut currently serves 80 million customers worldwide and views U.S. banking expansion as a major strategic milestone

The Alliance for Automotive Innovation, representing major automakers including GM, Ford, Toyota, and Volkswagen, is urging Congress to pass legislation banning Chinese vehicles from the U.S. market before year-end. The industry group cites concerns about Chinese automakers 'dumping subsidized vehicles with connected software and hardware around the world' as a threat to U.S. interests.

• The alliance represents major automakers including General Motors, Ford, Toyota, Volkswagen, Hyundai, Honda, and Stellantis
• CEO John Bozzella stated that while Chinese automakers haven't entered the U.S. market yet, the 'scale and urgency of this threat' requires immediate legislative action
• The request focuses on banning not just Chinese vehicles but also their connected software and hardware components

PayPal has laid off approximately 220 employees in India as part of a multi-year restructuring plan announced earlier in 2024. The cuts are part of broader cost-saving initiatives targeting $400 million in savings by year-end and $1.5 billion over the next two to three years. The restructuring comes as PayPal faces increased competition in the payments market and amid recent takeover speculation.

• PayPal is implementing organizational changes to reduce layers, improve productivity, and integrate AI and automation across operations
• The company recently raised its full-year profit forecast after quarterly results exceeded Wall Street expectations
• A consortium including Stripe and private equity firm Advent reportedly made a takeover bid for PayPal in July but is no longer pursuing the deal

AbbVie announced that its blood cancer therapy etentamig met primary goals in a late-stage clinical trial. The drug demonstrated a 74% overall response rate compared to 45.7% for standard treatments and also improved progression-free survival. This positive data supports the drug's potential advancement toward regulatory approval.

• Etentamig achieved a 74% overall response rate (ORR), significantly outperforming the 45.7% rate of standard investigator-chosen treatments
• The therapy met both primary endpoints: higher ORR and increased survival without disease progression
• ORR measures the percentage of patients whose cancer shrinks or disappears following treatment

U.S. weekly jobless claims rose marginally to 206,000 for the week ended August 29, staying near 2025's lower range and signaling continued stability in a 'slow-hire, slow-fire' labor market. Economists forecast August payrolls to rebound 56,000 after July's 23,000 decline, with the unemployment rate holding at 4.1%. Without labor market deterioration, the Federal Reserve may raise interest rates this month to combat inflation from tariffs and geopolitical tensions.

• Initial claims increased by just 2,000 to 206,000, remaining within the year's 189,000-230,000 range, while continuing claims rose 8,000 to 1.779 million, suggesting sluggish hiring is prolonging unemployment duration
• Planned hiring by companies increased 37% in the first eight months of 2025 year-over-year, but positions are filling slowly; planned job cuts rose 58% in August to 52,881, though total layoffs remain down 41% year-to-date
• Fed Chair indicated the central bank will 'have work to do' if inflation does not trend toward the 2% target, pointing to potential rate hikes as early as this month absent labor market weakening

Nvidia has agreed to acquire open-source AI platform Hugging Face for $12.9 billion, marking its second-largest acquisition ever. The deal expands Nvidia's presence beyond hardware and further up the AI stack while Hugging Face will remain an open platform for the AI ecosystem.

• This is Nvidia's second-biggest acquisition, following its $20 billion purchase of Groq assets in December 2024
• CEO Jensen Huang stated the acquisition will 'scale Hugging Face's platform, strengthen its infrastructure and expand access to AI for developers and institutions worldwide'
• Hugging Face was recently at the center of a cybersecurity incident involving powerful AI tools, which CEO Clément Delangue attributed to engineering mistakes

Volkswagen's supervisory board is set to vote on the automaker's largest-ever restructuring program, which could double planned job cuts to up to 70,000, close four plants, and carve out divisions. The plan faces fierce opposition from unions and Lower Saxony, which holds a 20% stake with blocking rights under the 1960 Volkswagen Law, potentially triggering a major conflict.

• The restructuring would cut vehicle lineup by up to half and reduce production capacity from 10 million to 9 million vehicles annually
• Volkswagen has fallen to third place in China (once its 'cash cow' market) behind BYD and Geely amid a local price war
• Lower Saxony's 20% stake grants blocking minority rights at shareholder meetings and requires supervisory board majority approval for plant closures, complicating management's restructuring efforts

Thomson Reuters disclosed a cybersecurity incident affecting its C-Track case management platform used by courts in 11 U.S. states, the U.S. Virgin Islands, and Canada. An unauthorized party accessed certain C-Track files in March, though the incident was not detected until June 30. Court records containing names and personal information were compromised, potentially affecting individuals involved in court proceedings.

• The breach affected court systems in Alabama, Pennsylvania, Kentucky, Montana, Nevada, North Dakota, South Carolina, Tennessee, Ohio, New Hampshire, Wyoming, the U.S. Virgin Islands, and Ontario, Canada
• Thomson Reuters engaged external cybersecurity experts, notified law enforcement, and secured the C-Track environment, with no operational disruption to the platform
• A contact center will be established on September 4 to respond to inquiries, though the specific information compromised and the party responsible remain unclear

Nestle announced a $393 million investment in Brazil's nutrition and health division through 2028, with $118 million allocated to build a new infant formula factory in Minas Gerais state. The facility will begin construction in 2027 and start operations in 2028, producing several infant formula brands to reduce import dependence and potentially create export opportunities.

• The nutrition and health investment represents approximately 30% of Nestle's total $1.37 billion commitment to Brazil between 2025 and 2028
• The new Ituiutaba factory will initially produce Nestogeno, Nestonutri, Ninho 1+, and Ninho 3+ infant formulas for the Brazilian market currently served partly through imports
• Nestle identifies Nutrition and Health as one of four strategic global growth priorities, representing some of the company's highest-value product categories